Atrion (NASDAQ:ATRI) is scheduled to announce its earnings results after the market closes on Wednesday, February 21st.
Atrion (NASDAQ:ATRI) opened at $561.25 on Wednesday. The stock has a market capitalization of $1,030.00, a PE ratio of 31.09 and a beta of 0.73. Atrion has a 1-year low of $459.05 and a 1-year high of $694.00.
Separately, BidaskClub cut Atrion from a “hold” rating to a “sell” rating in a report on Friday, December 29th.
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.